Regarding MCP-1, IL-4 and MCP-1 are reportedly involved in a “self-amplifying loop” in tumor microenvironment, whereby interleukin promotes MCP1 expression by endothelial cells, which, in turn, induces Th2 differentiation by up-regulating IL-4 synthesis [50]. The gene discussed is CCL2; the disease is neoplasm.